"Metastatic melanoma" trang 1 - tải miễn phí từ tailieuXANH
The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): A retrospective cohort quality improvement study to reduce the morbidity rates

The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): A retrospective cohort quality improvement study to reduce the morbidity rates
9    52    1
Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma

Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma
7    51    0
Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: A population-based analysis

Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: A population-based analysis
11    58    0
Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: A population-based cohort study in Ontario, Canada

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: A population-based cohort study in Ontario, Canada
10    56    0
An in-silico study examining the induction of apoptosis by Cryptotanshinone in metastatic melanoma cell lines

An in-silico study examining the induction of apoptosis by Cryptotanshinone in metastatic melanoma cell lines
13    53    0
Autoimmune comorbidities in patients with metastatic melanoma: A retrospective analysis of us claims data

Autoimmune comorbidities in patients with metastatic melanoma: A retrospective analysis of us claims data
9    66    0
Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: Case report and literature review

Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: Case report and literature review
5    71    0
Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: A case report

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: A case report
5    59    0
Case series: Indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma

Case series: Indoor-photosensitivity caused by fluorescent lamps in patients treated with vemurafenib for metastatic melanoma
4    53    0
Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles

Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
14    45    0
Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma

Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma
4    75    0
The DANTE trial protocol: A randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma

The DANTE trial protocol: A randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma
10    224    1
A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib

A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib
5    117    0
The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: An observational cohort study in Denmark

The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: An observational cohort study in Denmark
11    54    0
GNAQ mutation in a patient with metastatic mucosal melanoma

GNAQ mutation in a patient with metastatic mucosal melanoma
4    47    0
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study
10    133    1
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study
7    52    0
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: A case report

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: A case report
7    60    0
Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas

Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas
13    96    0
Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma

Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma
9    101    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.